Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding the Links among Maternal Diet, Myelination, and Depression: Preclinical and Clinical Overview. | Cells | 2022 | 35159347 | PubTator, text mining | PubMed |
| Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma. | Cancers (Basel) | 2022 | 35158973 | PubTator, text mining | PubMed |
| LPA2 promotes neuronal differentiation and neurite formation in neocortical development. | Biochem Biophys Res Commun | 2022 | 35151977 | PubTator, text mining | PubMed |
| Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. | Nat Commun | 2022 | 35136060 | PubTator, text mining | PubMed |
| Lateral access mechanism of LPA receptor probed by molecular dynamics simulation. | PLoS One | 2022 | 35113924 | PubTator, text mining | PubMed |
| The role of antifibrotic therapies in the treatment of systemic sclerosis-associated interstitial lung disease. | Ther Adv Musculoskelet Dis | 2022 | 35111241 | PubTator, text mining | PubMed |
| Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn's Disease Through the ATX-LPA Axis. | J Crohns Colitis | 2022 | 35104318 | PubTator, text mining | PubMed |
| DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients. | Epigenetics | 2022 | 35094644 | PubTator, text mining | PubMed |
| Flavanol Consumption in Healthy Men Preserves Integrity of Immunological-Endothelial Barrier Cell Functions: Nutri(epi)genomic Analysis. | Mol Nutr Food Res | 2022 | 35094491 | PubTator, text mining | PubMed |
| Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278. | Toxicol Appl Pharmacol | 2022 | 35090952 | PubTator, text mining | PubMed |
| CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma. | Sci Rep | 2022 | 35087132 | PubTator, text mining | PubMed |
| The regulation of FGF23 under physiological and pathophysiological conditions. | Pflugers Arch | 2022 | 35084563 | PubTator, text mining | PubMed |
| Insights into the genetic architecture of haematological traits from deep phenotyping and whole-genome sequencing for two Mediterranean isolated populations. | Sci Rep | 2022 | 35064169 | PubTator, text mining | PubMed |
| Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. | J Evid Based Integr Med | 2022 | 35018864 | PubTator, text mining | PubMed |
| Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study. | Biomech Model Mechanobiol | 2022 | 35000016 | PubTator, text mining | PubMed |
| LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer. | Med Oncol | 2022 | 34982278 | PubTator, text mining | PubMed |
| The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1. | Infect Agent Cancer | 2022 | 34980191 | PubTator, text mining | PubMed |
| Genomic insights in ascending aortic size and distensibility. | EBioMedicine | 2022 | 34968759 | PubTator, text mining | PubMed |
| Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development. | Gastroenterology | 2022 | 34951993 | PubTator, text mining | PubMed |
| Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies. | Diabetes Obes Metab | 2022 | 34882941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=26